Search Results For :: biotechnology
-
Molecular Spectroscopy Market by Technology (NMR (FT, Continuous Wave), UV-Visible (Array-based, Dual-beam), IR (Terahertz, Benchtop), NIR (FT-NIR), Raman (SERS, TERS, FT Raman)), Application (Pharmaceutical, Food, Biotechnology) - Global Forecast to 2022
The global molecular spectroscopy market is expected to reach USD 6.85 Billion by 2022 from USD 4.98 Billion in 2017, at a CAGR of 6.6%. The growth of this market is majorly driven by food safety concerns, the growth of the pharmaceutical and biotechnology industry, technological advancements in molecular spectroscopy and application of molecular spectroscopy in environmental screening. Bruker Corporation (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), and Agilent Technologies, Inc. (US) are the key players in the molecular spectroscopy market. Other players include Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Spiral Membrane Market by Polymer Type (Polyamide, PS & PES), Technology (RO, NF, UF, and MF), End-use Industry (Water & Wastewater Treatment, Food & Beverage, Pharmaceutical & Biotechnology, Oil & Gas), and Region - Global Forecast to 2023
The spiral membrane market is projected to grow from USD 5.10 billion in 2018 to USD 8.20 billion by 2023, at a CAGR of 10.0% from 2018 to 2023. Spiral membranes are used in a wide range of end-use industries, such as water & wastewater treatment, food & beverages, pharmaceutical & biotechnology, oil & gas, and chemical & petrochemical. They act as a selective barrier, allowing the passage of certain constituents while retaining others. These membranes are mainly termed as filtration elements and are widely used in commercial and industrial applications. With recent developments in spiral membrane materials and increasing demand for the reduction of energy consumption in the chemical processing industry, newer membranes and processes are being developed for new applications.. DowDuPont Inc. (US), Toray Industries, Inc. (US), Hydranautics (US), LG Water Solutions (South Korea), SUEZ Water Technologies and Solutions (France), Merck Group (Germany), Pentair plc (US), Koch Membrane Systems (US), Pall Corporation (US), and Lanxess (Germany) are the key players operating in the spiral membrane market.
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Gel Documentation Systems Market by Product (Instruments (Digital), Software), Light Source (Laser, LED, UV), Detection (Chemiluminescence), Application (Nucleic Acid), End User (Academic Institutes, Biotechnology Companies) & Region - Global Forecast to 2023
The gel documentation systems market is projected to reach USD 304 million by 2023, at a CAGR of 3.3%. Growth in the gel documentation systems market is mainly driven by the increasing prevalence of infectious and chronic disease, and rising research & development expenditure in the pharmaceutical and biotechnology companies. The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories, inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
EDS, WDS, EBSD, Micro-XRF Instruments Market by Product, by Application (Energy, Defense, Metals, Medical, Research, Agriculture, Nanotechnology, Electronics, Biotechnology, Automotive, Pharmaceutical, Oil and Gas) - Global Forecasts to 2019
The global EDS, WDS, EBSD, and Micro-XRF instruments market is segmented on the basis of products, applications, and regions. Based on products, the market is categorized into EDS, WDS, EBSD, and Micro-XRF. The EDS segment accounted for a major share of the market, by product, in 2014. The global EDS, WDS, EBSD, and Micro-XRF instruments market is expected to reach USD 1,529.6 Million by 2019 from USD 403.6 Million in 2014, at a CAGR of 5.6% during the forecast period.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029
According to MarketsandMarkets, the global Specialty enzymes market size is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% during the forecast period. Key players in this market include BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), Advanced Enzyme Technologies (India), Amano Enzyme Inc (Japan), F. Hoffmann-La Roche Ltd (Switzerland), New England Biolabs (US), BBI Solutions (UK), Creative Enzymes (US), Bioseutica (Netherland), and SEKISUI Diagnostics (US)
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Global Biotech Industry Outlook 2025
The global biotech industry market size is estimated to grow from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, at a growth rate of ~13.0%. The industry will see expanded use of biologic drugs, such as monoclonal antibodies and gene therapies, especially for complex diseases like cancer, genetic disorders, and autoimmune conditions.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Plant Breeding and CRISPR Plants Market by Type (Conventional Breeding and Biotechnological Method), Trait (Herbicide Tolerance, Disease Resistance, Yield & Grain Size Improvement, Temperature Tolerance), Technology, Application, and Region - Global Forecast to 2030
The global plant breeding and CRISPR plants market is projected to reach USD 13.86 billion by 2030, growing at a CAGR of 9.2% during the forecast period. The report profiles key players such as Bayer AG (Germany), KWS SAAT SE & Co. KGaA (Germany), Corteva (US), BASF (Germany), UPL (India), Rijk Zwaan Zaadteelt en Zaadhandel B.V. (Netherlands), Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA. (Switzerland), Sanatech Seed Co.,Ltd. (Japan), and Pairwise (US).
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 69
